Funded Tech Companies
Syremis Therapeutics
Syremis Therapeutics is a leading biopharmaceutical tech company, located in Boston. Investment came from GV, Dexcel Pharma and Third Rock Ventures.
Company Overview
Company Name
Syremis Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Boston, MA Undisclosed
USA
Boston, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health. The company's neuropsychiatric pipeline is rooted in emerging and clinically validated mechanisms, including muscarinic M1/M4 agonism and next-generation NMDA antagonism.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
12/18/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Elisabeth Kogan
Company Investors
- GV
- Dexcel Pharma (Ilan Oren)
- Third Rock Ventures (Reid Huber)
- Bain Capital Life Sciences (Ray Sanchez)
- QVT Fund
- Pictet
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs